SCHEMBL24714543

SCHEMBL24714543

CN(C)NC(=O)c1ccnc(C(C)(C)C)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 2/20 0.35
LMNA P02545 4/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
RECQL P46063 1/20 0.35
MCL1 Q07820 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
SYK P43405 1/20 0.33
CBLB Q13191 1/20 0.33
PIK3CA P42336 3/20 0.32
PIK3CD O00329 2/20 0.32
PIK3CB P42338 2/20 0.32
PIK3CG P48736 2/20 0.32
CNR2 P34972 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24925438 0.82 HDAC1 (0.42) KDM4ELMNANPC1RAB9ASMN1; SMN2
SCHEMBL24925529 0.81 P2RX7 (0.49) ALDH1A1KDM4ELMNASMN1; SMN2GAA
SCHEMBL24350428 0.79 SORT1 (0.38) ALDH1A1KDM4ELMNANPC1RAB9A
SCHEMBL12341063 0.79 ALDH1A1 (0.38) ALDH1A1KDM4EMAPTMAPK1SYK
SCHEMBL24714547 0.77 CNR1 (0.44) ALDH1A1KDM4ELMNASMN1; SMN2MAPT
SCHEMBL13043849 0.76 ALDH1A1 (0.42) ALDH1A1KDM4ELMNANPC1RAB9A
SCHEMBL2627832 0.76 KDM4E (0.49) ALDH1A1KDM4ELMNASMN1; SMN2MAPT
SCHEMBL31506349 0.76 KDM4E (0.49) ALDH1A1KDM4ELMNASMN1; SMN2MAPT
SCHEMBL24350416 0.75 IRAK4 (0.38) ALDH1A1KDM4ELMNANPC1RAB9A
SCHEMBL13043958 0.75 GABRP (0.35) ALDH1A1KDM4ESMN1; SMN2MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220235032-A1 BISHETEROCYCLIC CARBONYL SUBSTITUTED DIHYDROPYRAZOLE COMPOUND, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF GENFLEET THERAPEUTICS (SHANGHAI) INC. (CN) 2022-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220235032-A1 BISHETEROCYCLIC CARBONYL SUBSTITUTED DIHYDROPYRAZOLE COMPOUND, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF RIPK1, RIPK4, RIPK3 ALDH1A1 3224/4885KDM4E 2795/4885LMNA 1670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.